ArticleAdvances in therapy2025
Multi-specialty Physician Preferences and Perceptions in Treatment and Management of Polycystic Ovary Syndrome in China: Survey and Discrete Choice Experiment.
Article in Advances in therapy, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionPolycystic ovary syndrome (PCOS) is one of the most common gynecological endocrine diseases in reproductive-aged women. Given the multifaceted nature of PCOS and the involvement of multiple disciplines, the diagnosis and treatment of PCOS vary among different specialties. Our study aimed to elicit preferences of physicians from multidisciplinary specialties for PCOS treatment and their perceptions of PCOS management to enhance the understanding of clinical practice in China.
methodsA discrete choice experiment (DCE) was conducted to elicit the physicians' preferences of PCOS treatment, and a cross-sectional survey was performed to understand the perceptions in management of PCOS. Physicians from three hospital specialties (general gynecology, gynecological endocrinology, and reproductive endocrinology) in China were included.
resultsResponses from a total of 123 physicians were eligible for the final analysis, with 41 from each specialty. In DCE, the physicians mainly preferred the anti-androgen effect, lower probability of irregular bleeding, and additional benefits when selecting treatment for PCOS, and the decision making was found to be highly dependent on the presence of clinical hyperandrogenism. Regarding diagnostic criteria, polycystic ovary morphology (PCOM) was the most frequently used (39.84%), followed by menstrual dysfunction (37.40%) and clinical hyperandrogenism (30.08%). Fertility and menstruation regulation were selected as the most important treatment goals for PCOS by physicians. Similar preferences across the three specialties were observed.
conclusionThe decision making by physicians on PCOS treatment largely relies on the presence of clinical hyperandrogenism across all three specialties, indicating the significance of hyperandrogenism assessment in clinical practice, and the role of biochemical hyperandrogenism in PCOS treatment may require further elucidation in future clinical guidelines. Furthermore, the results emphasize the urgent need to bridge the gap between the clinical practice and guidance recommendations for the diagnosis and treatment of PCOS in China.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.